Nexiclon Xr Tablet, Extended Release
NDC Package 71511-503-30
Package Information
Nexiclon Xr (clonidine) tablets is a medication used alone or with other medications to treat high blood pressure (hypertension). This formulation utilizes a tablet, extended release delivery system. Marketed by Rosemont Pharmaceuticals Llc, this product is identified by NDC 71511-503 and is authorized under FDA application NDA022500.
Identification & Billing
- RxCUI: 1050338 - Nexiclon 0.17 MG 24HR Extended Release Oral Tablet
- RxCUI: 1050338 - 24 HR clonidine 0.17 MG Extended Release Oral Tablet [Nexiclon]
- RxCUI: 1050338 - 24 HR Nexiclon 0.17 MG (equivalent to clonidine HCl 0.2 MG) Extended Release Oral Tablet
- RxCUI: 1050338 - 24 HR Nexiclon 0.17 MG Extended Release Oral Tablet
- RxCUI: 1050338 - Nexiclon XR 0.17 MG 24 HR Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71511 - Rosemont Pharmaceuticals Llc
- 71511-503 - Nexiclon Xr
- 71511-503-30 - 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
- 71511-503 - Nexiclon Xr
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71511-503-30 identifies a specific commercial package of 30 tablet, extended release in 1 bottle, plastic of Nexiclon Xr, a human prescription drug labeled by Rosemont Pharmaceuticals Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package. This tablet, extended release is formulated for oral use and contains clonidine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rosemont Pharmaceuticals Llc on March 01, 2022. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
This medication is used alone or with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Clonidine belongs to a class of drugs (central alpha agonists) that act in the brain to lower blood pressure. It works by relaxing blood vessels so blood can flow more easily.
How is this Rosemont Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71511050330. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.